Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-059947

Director sold 20,054 shares at $10.63 ($213,144)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Borgeson Blake · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-26 Sale : show line 1 in the form 10b5-1 −20,054 $10.63 $213,144 7,364,472 D
Open-market sales · 20,054 sh · avg $10.63 · $213,144
Loading xslF345X05/doc4.xml…